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Abstract
Background and aim Dietary fat intake has long been associated with fatty liver. Our study aimed to determine the effect of
dietary fats on longitudinal fatty liver index (FLI) trajectories from adolescence to young adulthood.
Methods Nine hundred eighty-five participants in the Raine Study, Perth, Western Australia, Australia, had cross-sectional
assessments at ages 14, 17, 20 and 22 years, during which anthropometric measurements and blood tests were obtained. FLI
trajectories were derived from the longitudinal FLI results. Dietary fat intake was measured with a semi-quantitative food
frequency questionnaire at 14 years and log multinominal regression analyses were used to estimate relative risks.
Results Three FLI trajectories were identified and labelled as stable-low (79.1%, N = 782), low-to-high (13.9%, N = 132),
and stable-high (7%, N = 71). The low-to-high group associated with an increased intake of the long-chain polyunsaturated
fatty acids EPA, DPA and DHA (RR 1.27, 95% CI 1.10–1.48) relative to the stable-low group. Compared to the stable-low
group, omega-6 and the ratio of omega-6 to omega-3 in the stable-high group were associated with an increased relative risk
of 1.34 (95% CI 1.02–1.76) and 1.10 (95% CI 1.03–1.16), respectively.
Conclusion For those at high risk of fatty liver in early adolescence, high omega-6 fatty acid intake and a high ratio of
omega-6 to omega-3 fatty acids are associated with increased risk of fatty liver. There should be caution in assuming these
associations are causal due to possible undetected and underestimated confounding factors.
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Abbreviations
AIC	Akaike’s information criterion
ALA	Alpha-linolenic acid
ALT	Alanine transaminase
AST	Aspartate aminotransferase
BMI	Body mass index
CI	Confidence interval
CHO	Carbohydrates
DHA	Docosahexaenoic acid
DPA	Docosapentaenoic acid
EPA	Eicosapentaenoic acid
FFQ	Food frequency questionnaire
FLD	Fatty liver disease
FLI	Fatty liver index
GBTM	Group-based trajectory modelling
GGT	Gamma‐glutamyl transferase
HDL-C	High-density lipoprotein cholesterol
HOMA-IR	Homeostasis model assessment for insulin
resistance
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LA	Linolenic acid
LDL-C	Low‐density lipoprotein cholesterol
LH	Low to high
MUFA	Monounsaturated fats
n–3LCPUFA	Omega -3 long-chain polyunsaturated fatty
acids
n–3	Omega-3 fatty acids
n–6	Omega-6 fatty acids
N6:N3	Ratio of omega-6 and omega-3
PUFA	Polyunsaturated fats
RRs	Relative risks
SFA	Saturated fats
SH	Stable high
SL	Stable low
TFA	Total fats
TG	Triglycerides

Introduction
The contribution of an unhealthy diet, including excessive
fatty food, to development of fatty liver has been described
over nearly two centuries [1]. Non-alcoholic fatty liver disease (NAFLD) is the most common form of fatty liver disease (FLD), with an estimated global prevalence of up to
24% [2] and causes a substantial economic burden to society
[3]. The influence of rising obesity prevalence [4, 5], sedentary lifestyle [6], and unhealthy dietary patterns [7] on
development of fatty liver has previously been reported in
adolescents and young adults. Furthermore, dietary fats are
considered to affect the pathogenesis of fatty liver [8].
Although some observational studies [9, 10] and dietary
intervention studies [11–13] have attempted to clarify the
cross-sectional relationship between dietary fats and fatty
liver, there is no longitudinal study investigating the relationship between dietary fat intake and fatty liver occurrence and
development in adolescents and young adult populations.
In the Raine Study, a prospective association between the
high-fat “Western dietary pattern” and ultrasound detected
NAFLD in adolescents was found [7]. A feature of the western dietary pattern were foods high in fat such as take away
foods, processed meats and fried potatoes; therefore, we
aimed to test the hypothesis that high intake of dietary fat is
prospectively associated with fatty liver in adolescents and
young adults.
The primary aim of this study was to examine the association between baseline dietary fatty acids intake during
early adolescence and subsequent longitudinal fatty liver
trajectories as measured by fatty liver index (FLI) from
adolescence to young adulthood. A non-invasive diagnostic
model, such as FLI (based on waist circumference, body
mass index (BMI) triglycerides and gamma-glutamyl-transferase) is considered an accurate and validated method of
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determining NAFLD in population-based epidemiological
studies [14]. To achieve our primary aim, we identified distinct FLI trajectories from 14 to 22 years in the Raine Study
and tested the association of early dietary fats in adolescents
with these trajectories.

Methods
Study population
We utilised data from the Raine Study, a longitudinal
cohort study in Perth, Western Australia that started as a
randomised controlled trial to study the effects of frequent
and repeated ultrasound scans on pregnancy outcomes. The
background and methods of the Raine Study have previously been described [7]. Briefly, the original cohort of pregnant study participants (Gen1) was recruited between 1989
and 1992, at between 16 and 20 weeks gestation, resulting in 2868 live births. Follow-up assessments of the offspring (Gen2) cohort have been conducted approximately
every 3 years. Approximately 70% of the Gen2 participants
remained actively involved in the study at the 22-year follow-up. Clinical, biochemical and questionnaire data were
collected from serial assessments during antenatal/perinatal
stages, infancy, childhood, adolescence and adulthood [15].
Laboratory examination and physical measurement data
from the 14-, 17-, 20- and 22-year follow-ups of the cohort
were used in this study (see Fig. 1 for detailed information
on participant recruitment).
Institutional ethics committee approval was obtained from
the University of Western Australia Human Research Ethics Committee. Signed informed parental or primary carer
consent during Gen1 pregnancy, Gen2 childhood and adolescence, and subsequently by Gen2 adolescents and young
adults were obtained before participation in each assessment.

Dietary fat intake assessment
A dietary fat intake assessment at 14 years was obtained
from a validated semi-quantitative food frequency questionnaire (FFQ-14) developed by the Commonwealth Scientific
and Industrial Research Organisation (CSIRO) in Adelaide,
Australia, as previously described [16] and evaluated [17].
The parents or primary carer completed the FFQ-14 as being
representative of usual dietary and nutrient intake in the
previous 12 months [18]. The study nurse checked FFQ-14
responses during the clinical follow-up to clarify responses.
All data from the FFQ-14 were verified by CSIRO twice,
and Australian food composition data were applied to obtain
estimates of usual food and nutrient intakes [19]. These
included estimates of macro and micronutrients, including specific dietary fats [18] (TFA, total fatty acids; SFA,
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Fig. 1  The Raine Study participant recruitment in this study detailed
flowchart on participants in this study. Laboratory examination and
physical measurement data from the 14, 17-, 20- and 22-year follow-

up of the West Australian Pregnancy Cohort (Raine) Study are used
to identify distinct FLI trajectories

saturated fatty acids; PUFA, polyunsaturated fatty acids;
MUFA, monounsaturated fatty acids; total omega-3 fatty
acids (including alpha-linolenic acid and long-chain n–3),
n–3; total omega-6 fatty acids (including gamma-linolenic
acid and linoleic acid), n–6; long chain omega-3 PUFA
(Eicosapentaenoic Acid, EPA + Docosapentaenoic Acid,
DPA + Docosahexaenoic Acid, DHA), n–3 LCPUFA; and
the ratio of total n–6 to total n–3 fatty acids, n–6:n–3). The
FFQ-14 did not collect dietary fish oil supplement intake.

dietary misreporting in the Raine study was determined
using the Goldberg method [21], which estimates the cutoffs for plausible reporting based on energy intake relative
to basal metabolic rate. These cut-off values classify study
participants as under-, plausible- or over-reporters of dietary
intake. The method has been used widely to identify misreporting from dietary surveys and studies [22]. Because
dietary underreporting may be strongly associated with the
risk of overweight [23], we considered excluding underreporters. However, excluding under-reporters removes
participants at the highest risk, reducing our sample size
considerably. We, therefore, created a categorical variable
for misreporting where all participant data were included
in the analysis. This categorical variable for misreporting

Dietary misreporting
Dietary misreporting can contribute to measurement error
in the analysis of diet–disease relationships [20]. Potential
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was included as a covariate in our regression models. Similarly, when we summarise participants’ dietary fat intake at
baseline, there is a significant difference in the proportion
of dietary misreporting between trajectory groups. Therefore, we show the dietary data for plausible reporters only
in Table 2 and data of the entire cohort with all categories of
dietary reporting included in supplementary Table 3.

Anthropometric and laboratory measurements
At all years, a trained research assistant weighed and measured participants in light clothing for height and weight
using a calibrated stadiometer and electronic chair scales.
Body mass index (BMI = weight (kg)/square of the height
(m2)) was calculated, and subjects were categorised as
underweight, normal weight, overweight and obese using the
International Obesity Task Force (IOTF) criteria at 14 years
[24, 25]. Blood was taken by a phlebotomist at the home of
the participants from an antecubital vein after an overnight
fast. Laboratory assessments were performed in the PathWest Laboratories, Perth, for serum glucose, insulin, alanine transaminase (ALT), aspartate aminotransferase (AST),
gamma-glutamyl transferase (GGT), triglycerides (TG), total
cholesterol, high-density lipoprotein cholesterol (HDL-C),
low-density lipoprotein cholesterol (LDL-C), ferritin, transferrin saturation, high-sensitivity C-reactive protein (hsCRP), adiponectin, serum glucose, serum insulin and leptin.

Fatty liver index trajectories
The lack of an accurate, non-invasive, easily accessible and
affordable diagnostic test is an important factor limiting
research regarding fatty liver in the general population. The
FLI is an algorithm based on WC, BMI, TG and GGT. The
index was initially developed to detect fatty liver [26]. It is a
relatively reliable tool for fatty liver research, recommended
by a group of European Societies for diagnosis of fatty liver
in epidemiological studies [14] and has been validated in the
Raine Study cohort [27]. The FLI has been shown to have
the best calibration performance compared to other prediction models attempting to identify fatty liver disease. This
suggests that the FLI has a good ability to predict the risk of
fatty liver among study participants at the individual level.
We hypothesised that FLI is useful as a continuous variable in repeated measurements of longitudinal data to detect
changes in fatty liver risk. To answer our research question,
we applied a trajectory model to describe the natural history
of fatty liver over eight years in Raine Study participants
from adolescence (14 years) to young adulthood (22 years)
using the FLI (Fig. 2).
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Fig. 2  A group-based trajectory analysis of fatty liver index from 14
to 22 years (985 participants) in the Raine Study. The main dots on
each trajectory represent, from left to right, the follow-up nodes from
baseline (14 years) to 17, 20 and 22 years. Dotted lines either side of
the trajectories are 95%CI curves. SL stable low risk, (N = 782); LH
low risk to high risk, (N = 132); SH stable high risk, (N = 71)

Covariate assessment
In the multivariate analyses of this study, there were three
main types of model covariates. (1) Energy-adjusted variables, such as total energy and dietary misreporting (Model
1). (2) Demographic background variables of the cohort,
such as sex, screen time and family income (Models 2 and
3). 3) Other dietary nutrient exposures and potential mediating variables included dietary patterns, total carbohydrate
intake, total protein intake and homeostasis model assessment for insulin resistance (HOMA-IR) (Models 4, 5 and 6).
At each follow-up, medical status was reported, and
participants with chronic diseases or use of potentially
steatogenic medications (such as amiodarone and methotrexate) were excluded from the analysis. The primary
caregivers of the participants were asked to report their
annual family income (in Australian dollars) at the 14 year
follow-up (2003–2006) and categorised as: < $ 30,000,
$30,001–50,000, $50,001–78,000, and > $78,000. Parental
education level and BMI were not assessed at our baseline
follow-up (14 years). Also, at the 14-year follow-up, hours of
physical activity per week were assessed through the International Physical Activity Questionnaire (IPAQ). Participants
or their primary caregiver reported the time and frequency
spent in exercising vigorously during physical education at
school and outside school. Screen time, including time spent
using a computer, was collected through a questionnaire
with response options from ‘none at all’ to ‘4 h or more’
per day by participants’ primary caregivers. Considering
that an analysis-adjusted sample using the physical activity
level variable would lose much of the sample relative to the
computer viewing (sedentary activity) variable, especially in
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some of the higher metabolic risk groups. We used the adolescent computer viewing (sedentary activity) variable for
the analysis in order to obtain a larger sample with metabolic
outcome. Therefore, screen time was used for the analysis to
obtain a larger sample with more metabolic outcomes. The
Raine Study has identified [16], evaluated [17] and applied
[7] Western and healthy dietary patterns score in previous
studies. In brief, these dietary pattern scores were developed
using dietary data collected from the CSIRO FFQ at 14 years
of age from 38 pre-defined food groups, with significant
differences in fat and sugar intakes between the healthy and
western dietary patterns [16]. Dietary pattern scores were
adjusted as covariates in the regression models. In addition,
other independent risk nutrients such as total carbohydrate
(CHO) and total protein intake from the CSIRO FFQ-14
data were adjusted in the models. The HOMA-IR score was
calculated as follows:

HOMA − IR score = Fasting serum glucose
∗ Fasting serum insulin∕22.5

Statistical analysis
Continuous descriptive data with normal distributions are
presented as means ± standard deviation (SD); non-normally
distributed data are reported as medians and interquartile
ranges (IQRs).
Trajectories were estimated with group-based trajectory
modelling (GBTM) [28]. The trajectories were derived by
modelling the FLI as a function over time (participants’ age
at each follow-up measurement). Data requirements for participants in the model were limited to having FLI data at the
14-year follow-up and at least one other follow-up (17, 20,
or 22 years).
The best-fit model was based on the Bayesian Information
Criterion (BIC) and the presence of a minimum of 5% of
participants per trajectory to ensure stable estimates [28, 29].
After setting the number of trajectories and non-significant
quadratic and cubic terms were removed, the best optimal
model was estimated by fit indices, pragmatic evaluation,
and clinical relevance. Fit indices included BIC and Akaike's
information criterion (AIC), with the lower the indices, the
better the model fit [28] (Supplementary Table 1). After the
model was built, we tested its accuracy with the conditions
suggested by Nagin [28]: the average posterior probability
of assignment of each group was 0.7 or higher; the odds
of correct classification was 5.0 or higher; the proportion
of samples allocated to a particular group was close to the
proportion estimated by the model, and the 99% confidence
interval for the estimated proportion was reasonably narrow
(Supplementary Table 2).

Dietary fat exposures were converted to Z-scores in the
log multinominal regression models to obtain appropriate
clinical interpretations. The total fats and sex interaction
effect was not significant in our study (P values for interaction effects: 0.080 in low–high FLD risk group to Stable-low
FLD risk group regression and 0.084 in stable-high FLD risk
group to Stable-low FLD risk group regression). However,
sex interaction effects of MUFA and n–3 dietary variables
were significant in regression models for the stable-high to
stable low FLD risk group (Supplementary Table 8). The
conclusions of our analysis are based on the combination of
the entire dataset for males and females; however, results of
sex subgroup analysis are given in the supplementary material (Supplementary Table 9–15, Supplementary Figs. 1–3).
Log multinominal regression analyses were conducted to
estimate relative risks (RRs) and 95% confidence intervals
(CIs) with multiple attributes [30] of three distinct FLI
trajectories (stable-high FLD risk SH; low–high FLD risk
LH) using the “stable-low FLD risk, SL” trajectory groups
as a reference. RR and 95% confidence intervals (CIs)
were reported for each FLI trajectory as follows: model 1
adjusted for total energy intake plus dietary misreporting;
model 2 adjusted for model 1 plus sex; model 3 adjusted
for model 2 plus computer viewing, and family income. We
used the standard multivariate model instead of nutrient
density for energy adjustment. This is because if nutrient
density is used, nutrient intake will be confounded by total
energy intake (in the opposite direction) as it is divided by
total energy when the disease is also associated with total
energy intake. BMI was not in the model because the already
adjusted covariates of total energy intake, dietary misreporting and BMI were highly correlated, and additional adjustment for BMI could not be fitted to the model.
All analyses were performed using Stata 15.0 for Windows (Stata Statistical Software: College Station, Tx, USA).
P values < 0.05 were regarded as statistically significant.

Results
Our study population comprised 985 Gen2 adolescents aged
14 years. Participant characteristics at the 14-year follow-up
are presented by different FLI trajectory groups in Table 1.
The overall characteristics of the cohort showed 52% were
males, 89% were of Caucasian maternal race, and 42% of
the cohort had an annual family income over $70,000 at
baseline.
From the 985 eligible participants, three different FLI
trajectories were identified (Fig. 2) and labelled as “stablelow fatty liver risk, SL” (79.1%, N = 782, trajectory 1), “lowto-high fatty liver risk, LH” (13.9%, N = 132, trajectory 2)
and “stable-high fatty liver risk, SH” (7%, N = 71, trajectory
3). The rising FLI trajectory indicates an increased risk of
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Table 1  Characteristics of study population at baseline (14 years) by trajectory groups from 14 to 22 years in the Raine Study
Characteristic

Stable-low risk group

Low–high risk group

Stable-high risk group

Total

N
General
Sex† (proportion of males) (%)
Proportion with Caucasian mother (%)‡
Annual family income at baseline (%) **
< 35,000
35,000–70,000
> 70,000
Child lifestyle at 14 years
Dietary Misreporting (%)**
Underreporting
Plausible reporting
Overreporting
BMI (%)**
Underweight
Healthy weight
Overweight
Obese
Physical activity (%)
Once month or less
1–3 times per week
4 + times per week
Computer viewing (%)
< 2 h per day
2–4 h per day
> 4 h per day
Healthy pattern score
Western pattern score
Total CHO (g/day)
Total protein (g/day)
Biochemistry (mean and standard deviation)
ALT (U/L)**
AST (U/L)**
GGT (U/L)**
Total cholesterol (mmol/L)
Triglycerides (mmol/L)**
Insulin (mU/L)**
HDL‐C (mmol/L)**
LDL‐C (mmol/L)

782

132

71

985

50.1
87.6
N = 770
19.5
36.8
43.8

56.8
91.7
N = 131
23.7
35.9
40.5

57.8
93.0
N = 70
50.7
27.9
21.4

51.6
88.5
N = 971
22.4
35.9
41.7

22.3
66.2
11.5

29.6
62.1
8.3

46.5
52.1
1.4

25.0
64.7
10.3

3.1
83.6
11.8
1.5
N = 628
9.7
57.2
33.1
N = 778
80.2
13.5
6.3
− 0.01 (0.83)
− 0.08 (0.84)
274.0 (89.1)
94.1 (29.6)

0
40.0
41.7
18.3
N = 102
9.8
53.9
36.3
N = 135
71.2
18.2
10.6
0.20 (0.96)
0.07 (0.83)
281.5 (92.9)
100.4 (31.8)

0
2.8
14.1
83.1
N = 51
9.8
66.7
23.5
N = 70
75.7
17.2
7.1
− 0.24 (0.79)
0.01 (0.99)
261.9 (81.9)
93.1 (28.6)

2.4
72.0
16.0
9.6
N = 781
9.7
57.4
32.9
N = 983
78.5
14.5
7.0
0 (0.85)
− 0.06 (0.85)
274.2 (89.1)
94.8 (29.8)

16.19 (6.77)
46.58 (2.51)
11.10 (4.31)
4.17 (0.68)
0.95 (0.43)
11.16 (7.40)
1.44 (0.32)
2.30 (0.61)

17.74 (10.38)
46.35 (2.67)
11.77 (3.72)
4.09 (0.76)
1.08 (0.45)
13.01 (6.27)
1.29 (0.28)
2.31 (0.66)

23.06 (10.35)
45.90 (2.67)
16.55 (6.75)
4.30 (0.81)
1.51 (1.18)
22.91 (14.13)
1.13 (0.01)
2.47 (0.71)

16.89 (7.84)
46.50 (2.52)
11.58 (4.67)
4.17 (0.70)
1.01 (0.54)
12.25 (8.49)
1.39 (0.32)
2.31 (0.63)

ALT alanine transaminase; AST aspartate aminotransferase; BMI body mass index; CHO carbohydrates; FFQ food frequency questionnaire; GGT
gamma‐glutamyl transferase; HDL-C high-density lipoprotein cholesterol; LDL-C low‐density lipoprotein cholesterol; LH low risk to high risk;
SH stable high risk, SL stable low risk;
The results are presented as means and standard deviations except for percentages
*For P < 0.05 and ** for P < 0.01 for the difference within groups
†
‡

Baby’s sex was recorded at birth
Proportion with Caucasian mother data were collected at study recruitment 16–20 weeks gestation
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fatty liver for the individual in the SH group. The majority of participants (79%, N = 782) maintained a SL fatty
liver risk from 14 to 22 years, while 7% (N = 71) and 14%
(N = 132) were categorised in SH and LH fatty liver risk
groups, respectively. For the demographic characteristics in
the trajectory groups at baseline (Table 1), the SH group had
the highest proportion of males (57.8%), Caucasian maternal
race (93.0%) and annual family income less than $35,000
(50.7%). The SH group also had higher serum ALT, GGT,
triglycerides, insulin and lower HDL-cholesterol, which may
represent increased cardiometabolic risk. Lifestyle characteristics, such as dietary misreporting and BMI, were significantly different between the three trajectory groups. In
the SH group, nearly 46% were under reporters as identified
from the dietary misreporting analysis. The majority of subjects in the SL group (nearly 84%) were categorised as being
within the healthy weight range. Progressively, the proportion of healthy weight versus overweight was similar in the
LH group (40 vs 42%, respectively). Furthermore, 97% of
participants in the SH group were categorised as overweight
or obese. Among the laboratory biochemical indicators
shown in Table 1, the SH group had the highest mean levels
of all the biomarkers other than AST and HDL-C.
The baseline dietary fat intake characteristics are shown
in Table 2 for plausible reporters only. Considering the
group variations in energy requirements, the percentage of
energy intake from specific TFA, SFA and MUFA categories of dietary fats are also reported. Energy intake from
the fat categories n–3 LCPUFA, n–3 and n–6 are not shown
because energy levels of these nutrients were very low. All
indicators of fat intake characteristics (including absolute

value and percentage of energy) were non-normally distributed. For most indicators, except for n–3 and n–3 LCPUFA,
the SH risk group had the highest median intake of all dietary fats and percentage of energy compared to the SL and
LH groups. For n–3 and n–3 LCPUFA, the LH group had
the highest median intake level (total n–3 1.3 g/day and n–3
LCPUFA 288 mg/day). Except for SFA, the absolute value
of most fat categories (TFA, PUFA and MUFA) showed the
same trend as the percentage of energy. However, for SFA,
the median absolute value of SFA in the LH group is moderate but accounts for the lowest median energy percentage
(absolute value: 41.5 (g/day), energy percentage: 14.4%).
Table 3 shows the results from multinomial analysis of
the correlation between baseline dietary fats and FLI trajectories with the SL group as the reference group for each
dietary fats exposure. The RR of the multinomial analyses
shows n–3 LCPUFA and N-3: N6 at baseline (14 years) were
significantly associated with the FLI trajectories after adjusting for all covariates. N-3 LCPUFA in the LH group relative to the SL group has a RR of 1.27 (95% CI 1.07–1.51)
in model 5. Compared to the SL group, N-3: N6 in the SH
group has RRs of 1.37 (95% CI 1.10–1.70) in model 5.
Supplementary Table 3 shows that the intake of dietary
fats was lower in the SH group compared to that of the
LH and SL groups. This may be due to the 46.5% underreporting in the SH group (Table 1). Nevertheless, this relationship is different in n–3 fatty acids and n3 LC-PUFA,
with the intake of LH group the highest, while the intake
of SH group is lower than that of LH group. Supplementary Table 4 shows the results of regression analyses for
the DPA, EPA, DHA, ALA and LA. In a regression model

Table 2  FFQ dietary fat intake characteristics of participants at age 14 years presented as median and interquartile ranges (Q1, Q3) (Plausible
reporters only) in the Raine Study
Dietary fats at 14 years (g/day)

Stable-low risk group

Low–high risk group

Stable-high risk group

P value

N
TFA
Energy from TFA (%)
SFA
Energy from SFA (%)
PUFA
Energy from PUFA (%)
MUFA
Energy from MUFA (%)
n–3
n–3 LCPUFA (mg/day)
n–6
N6: N3

518
89.9 (75.9,104.6)
34.9 (31.5,38.6)
39.2 (32.3,47.2)
15.3 (13.1,17.4)
12.6 (9.7,17.7)
5.1 (3.8,6.3)
31.2 (26.1,36.1)
12.1 (10.7,13.3)
1.2 (1.0,1.5)
231.0 (164.8,306.9)
10.3 (7.8,14.6)
9.1(6.6,11.9)

82
98.3 (79.3,113.8)
35.2 (31.7,39.0)
41.5 (32.7,49.4)
14.4 (12.3,16.9)
16.1 (11.5,20.2)
5.7 (4.0,7.1)
34.8 (27.4,42.3)
12.3 (10.6,14.1)
1.3 (1.0,1.8)
288.4 (193.3,414.9)
12.9 (8.8,17.2)
9.7(6.8,12.5)

37
102.1 (88.0,117.3)
36.3 (32.1,39.3)
44.6 (38.1,53.3)
15.5 (14.2, 17.7)
16.8 (10.7, 20.3)
5.8 (3.9,7.0)
34.8 (30.5,40.0)
12.4 (11.1,13.4)
1.2 (1.1,1.5)
237.0 (167.2,301.1)
14.5 (9.2,17.2)
12.0(7.1,13.5)

0.646
0.746
0.775
0.154
0.099
0.122
0.551
0.321
0.046
0.008
0.081
0.015

DHA docosahexaenoic acid; DPA docosapentaenoic acid; EPA eicosapentaenoic acid; n–3 LCPUFA long-chain fatty acids (EPA + DPA + DHA);
LH low risk to high risk; MUFA monounsaturated fats; n-3 omega-3 fatty acids; N6: N3 the ratio of total n–6 and total n–3 fatty acids; n–6
omega-6 fatty acids; PUFA polyunsaturated fats; SFA saturated fats; SH stable high risk; SL stable low risk; TFA total fats
The results are presented as median and interquartile ranges (Q1, Q3)
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Table 3  Log multinomial regression models for each dietary fat (Z-score) at 14 years and different fatty liver index trajectories in the Raine
Study (stable low risk as the reference group)
Dietary fats (z-score) at 14 years
Total fat z-score
Model 1 (N = 985)
Model 2 (N = 985)
Model 3 (N = 966)
Model 4 (N = 966)
Model 5 (N = 966)
Model 6 (N = 966)
Saturated fat z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Polyunsaturated fat z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Monounsaturated fat z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Total omega‐3 z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
n–3 LCPUFA
(EPA + DPA + DHA) z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Total omega‐6 z-score
Model 1
Model 2
Model 3
Model 4
Model 5
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Low to high (LH) risk group

P value

Stable high (SH) risk group

P value

0.94 (0.64–1.37)
0.98 (0.68–1.43)
1.01 (0.70–1.46)
1.14 (0.74–1.78)
0.31 (0.05–2.13)
1.03 (0.72–1.48)

0.764
0.920
0.949
0.535
0.235
0.866

1.43 (0.80–2.55)
1.58 (0.90–2.78)
1.55 (0.90–2.65)
1.00 (0.50–2.01)
0.52 (0.02–13.90)
1.47 (0.89–2.42)

0.225
0.110
0.112
0.996
0.697
0.134

0.80 (0.61–1.04)
0.82 (0.63–1.08)
0.84 (0.65–1.11)
0.89 (0.65–1.23)
0.60 (0.38–0.94)
0.86 (0.66–1.12)

0.100
0.158
0.225
0.486
0.027
0.267

1.10 (0.74–1.63)
1.19 (0.81–1.75)
1.17 (0.83–1.66)
0.91 (0.59–1.41)
0.82 (0.45–1.50)
1.16 (0.81–1.67)

0.630
0.370
0.361
0.674
0.526
0.424

1.14 (0.94–1.37)
1.14 (0.94–1.38)
1.15 (0.95–1.39)
1.13 (0.934–1.36)
1.12 (0.92–1.37)
1.15 (0.95–1.40)

0.186
0.191
0.164
0.214
0.258
0.162

1.26 (0.95–1.65)
1.28 (0.96–1.71)
1.20 (0.89–1.61)
1.14 (0.86–1.52)
1.12 (0.84–1.49)
1.17 (0.88–1.55)

0.107
0.090
0.228
0.353
0.448
0.279

1.15 (0.81–1.61)
1.15 (0.82–1.60)
1.16 (0.84–1.62)
1.33 (0.90–1.95)
1.42 (0.78–2.56)
1.18 (0.85–1.63)

0.438
0.424
0.365
0.147
0.249
0.325

1.44 (0.85–2.42)
1.43 (0.88–2.33)
1.56 (0.96–2.54)
1.08 (0.56–2.08)
1.48 (0.53–4.12)
1.43 (0.91–2.24)

0.173
0.153
0.074
0.809
0.458
0.123

1.14 (0.97–1.33)
1.14 (0.97–1.33)
1.13 (0.97–1.32)
1.10 (0.93–1.28)
1.10 (0.93–1.31)
1.13 (0.97–1.33)

0.119
0.112
0.126
0.263
0.259
0.119

0.86 (0.61–1.19)
0.89 (0.64–1.23)
0.99 (0.71–1.38)
1.00 (0.70–1.41)
0.87 (0.58–1.30)
0.98 (0.70–1.38)

0.362
0.482
0.942
0.992
0.492
0.918

1.28 (1.11–1.47)
1.28 (1.11–1.47)
1.27 (1.10–1.48)
1.21 (1.04–1.41)
1.27 (1.07–1.51)
1.28 (1.10–1.48)

< 0.001
0.001
0.001
0.016
0.006
0.001

0.96 (0.73–1.25)
0.91 (0.70–1.18)
0.96 (0.75–1.24)
0.92 (0.71–1.18)
0.87 (0.65–1.17)
0.99 (0.75–1.31)

0.744
0.485
0.782
0.517
0.364
0.963

1.10 (0.91–1.32)
1.10 (0.92–1.33)
1.12 (0.93–1.34)
1.11 (0.93–1.33)
1.10 (0.91–1.33)

0.319
0.297
0.240
0.242
0.341

1.33 (1.05–1.70)
1.38 (1.08–1.78)
1.34 (1.02–1.76)
1.26 (0.95–1.66)
1.24 (0.94–1.64)

0.019
0.010
0.035
0.170
0.130
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Table 3  (continued)
Dietary fats (z-score) at 14 years

Low to high (LH) risk group

P value

Stable high (SH) risk group

P value

Model 6
Total n‐6: total n:3 z-score
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6

1.12 (0.93–1.35)

0.226

1.27 (0.99–1.64)

0.058

0.99 (0.94–1.03)
0.99 (0.95–1.04)
0.99 (0.95–1.04)
1.01 (0.86–1.19)
0.99 (0.83–1.17)
0.97 (0.82–1.14)

0.593
0.641
0.709
0.900
0.877
0.702

1.11 (1.05–1.17)
1.12 (1.06–1.19)
1.10 (1.03–1.16)
1.35 (1.08–1.68)
1.37 (1.10–1.70)
1.45 (1.15–1.81)

< 0.001
< 0.001
0.003
0.008
0.004
0.001

DHA docosahexaenoic acid; DPA docosapentaenoic acid; EPA eicosapentaenoic acid; HOMA-IR homeostasis model assessment for insulin
resistance; LH low risk to high risk; SH stable high risk; SL stable low risk
The results are presented as means and standard deviations
Model 1 adjusted for total energy + misreporting
Model 2 adjusted for Model 1 + sex
Model 3 adjusted for Model 2 + computer viewing + family income
Model 4 adjusted for Model 3 + Healthy pattern score + Western pattern score
Model 5 adjusted for Model 3 + total CHO + total protein
Model 6 adjusted for Model 3 + HOMA-IR

that incorporated DPA, EPA and DHA, none of the fatty
acids were significantly associated with the LH group (supplementary Table 5). Supplementary Table 6 indicates the
component characteristics of n3 LCPUFA intake (plausible
reporters only). DPA had the highest median level in the LH
group among the three trajectory groups.

Sensitivity analyses
We considered the interaction of gender and the robustness of the resulting trajectory modelling (Supplementary Table 8) with the same criteria and process for males
(N = 507) and females (N = 477) as a subgroup (Supplementary Tables 9 and 12). The results show that, similar to the
whole population, within the subgroups, trajectories fall
into three categories, i.e. a stable low-risk group, a low- to
high-risk group, and a stable high risk group (Supplementary Fig. 1, 2 and 3). The relative risk of dietary exposure
and trajectories were tested in the same way (Supplementary Table 11 and 15). Subgroup analyses suggest that the
association between n–6 and N6: N3 as a population risk
for the SH-SL group may be driven mostly by males (RR
of n–6: 1.45 (1.02–2.06), RR of N6: N3: 1.16 (1.07–1.25))
(Supplementary Table 15). In addition, a risk association
for monounsaturated fats in the SH-SL group was observed
in the female subgroup analyses (RR of monounsaturated
fats: 3.41(1.26–9.21)) (Supplementary Table 11). The
n-3 LCPUFA as a risk for the LH group (compared to SL
group) was predominantly driven by males. Furthermore,
in the male and female SH groups (compared to SL group),
n–3 LCPUFA showed contrasting effects (RR in male: 0.69

(0.48–0.97); RR in female: 1.46 (1.03–2.07)). In addition,
we extended the regression analysis to other individual
nutrients (e.g. sugars, dietary fibre and red meat) (Supplementary Table 16) in order to gain a more comprehensive
understanding and identify potential interactions between
different nutrients. After further adjustment for these nutrients the results were similar to the model results in the original manuscript, other than the effect of red meat on n–3
LCPUFA in the low- to high (LH) risk group (RR: 1.15
(0.97–1.38)). This may be related to the fact that red meat is
a major source of n-3 LCPUFA.

Discussion
We identified three different fatty liver index trajectories
from a young population in Western Australia and observed
a dietary fat intake relationship with these trajectories. The
majority of participants were in the SL group, with a sustained low FLI. The SH group had FLI at a relatively persistent high level, while the LH group changed from low- to
high-risk for FLD during follow-up. After controlling for
total energy, dietary misreporting, sex, computer viewing
and family income, intake of n–3 LCPUFA, n–6 and N6:
N3 at baseline were significantly associated with prospective and longitudinal FLI trajectories over eight years of
follow-up.
Our study provides a unique insight into the relationship of baseline dietary fatty acid intake on the natural history of fatty liver as assessed by trajectories of FLI from
adolescence to young adulthood. We show that fatty liver
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development follows specific trajectories over time in
young populations. FLI, as a predictor of fatty liver, has
been widely used in epidemiological studies as an alternative diagnostic tool for fatty liver. The FLI incorporates BMI
and our data show that adiposity is the main driver of the
FLI trajectories. The prevalence of fatty liver based on FLI
in 17-year-old adolescents in the Raine Study was 11.6%
[27]. Meta-analyses have shown that the prevalence of FLD
or NAFLD was 11.3% in children 10–14 years [31], 17.3%
in adolescents 15–19 years [32] and 24% in young adults
18–35 years [33]. Our FLI trajectory data show a similar
fatty liver disease trend from adolescents to young adults.
These findings are worthy of highlighting given the chronicity and severity of fat accumulation in the liver is associated
with subsequent risk of type 2 diabetes and cirrhosis later
in life [2]. Our findings also demonstrate the importance
of the transition from adolescence to young adulthood as a
critical period for health promotion and health intervention
to reduce the impact of chronic liver disease and cardiometabolic risk.
Our main finding is that a diet high in n–6 fatty acids or
a high N6: N3 ratio at 14 years of age associates with an
increased risk of FLD from adolescence to young adulthood.
This implicates n–6 fatty acids as a potential risk factor in
the development of FLD although this association may be
influenced by dietary patterns and the intake of carbohydrates and protein in the diet. Moreover, these findings are
similar to previous studies in which cross-sectional associations between N6: N3 and obesity [34] and fatty liver risk
[35] were observed. In a typical Western diet, the ratio of
N6: N3 is usually 15–16:1, rather than the recommended
1–4:1, which is considered the healthy range [36].
The association between N6: N3 and risk of FLD was
robust in our study. Nuts and seeds are rich in n–6, which is
why large amounts of n–6 can be found in refined vegetable
oils such as palm oil and sunflower oil and foods cooked
with these vegetable oils. Vegetable oils are a widely used
source of fatty acids in the food industry for processed
snacks, fast foods, cakes and cured meats that are also rich
in n–6 and high in the ratio of N6: N3 [37]. Our study did
not support saturated fatty acids as a risk factor for FLD. In
the LH group, the risk of FLD was reduced if total carbohydrate and total protein were replaced with the same amount
of energy from saturated fat to provide energy (Model 5).
Disordered physiologic states related to the metabolic syndrome are recognised risk factors for the development of
fatty liver disease in children and adults, and insulin resistance is thought to be a key pathogenic mechanism in the
development of FLD [38]. Results from analyses adjusted for
HOMA-IR suggest that insulin resistance may not significantly influence the association between dietary fatty acid
intake and FLI trajectory.
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Another interesting finding suggested here is that there
could be a positive association between n–3 LCPUFA and
liver fat. Whilst interesting, these data do not accord with
clinical trials and meta-analyses that suggest n–3 LCPUFA
may benefit fatty liver [39]. We consider this may be related
to the misclassification of n–3 LCPUFA using FFQ data.
It was noted that when using FFQ data to identify individuals with low n–3 PUFA intake, the FFQ was able to
better capture DHA and EPA intake as opposed to ALA
and total n–3 when compared to red blood cell or plasma
fatty acid levels [40, 41]. Furthermore, dietary fatty acid
nutrient intake levels and their food sources are positively
correlated with body weight or BMI levels, meaning that
heavier individuals consume more nutrients to maintain a
balanced energy metabolism. This makes the weight factor
a possible mediator in the study of nutritional epidemiology
and metabolism-related outcomes. As BMI was one of the
main drivers of FLI trajectories in our study, the potential
positive association of fatty acids and their food sources with
BMI could influence the risk of developing FLD. On the
other hand, when individual intake levels were examined
using the FFQ, overweight or obese individuals were more
likely to under-report nutrient intake (as determined from the
data shown in Table 2 and Supplementary Table 3). Thus,
individuals with more severe metabolic outcomes (typically
higher BMI) appear to have lower dietary intakes. We identified three trajectory groups with an increasing distribution in terms of metabolic outcomes (SH more severe than
LH and LH more severe than SL) and dietary misreporting
was progressive when underreporting was considered (more
severe for SH than LH and more severe for LH than SL).
This in turn reinforced the relative risk for the LH group
as misreporting was more severe in the SH group than in
the LH group. These findings suggest that the effect of n-3
LCPUFA may be overestimated, as the LH group had the
highest level of n-3 LCPUFA FFQ intake level regardless
of whether dietary misreporting were taken into account
(Table 2 and Supplementary table 3). In addition, sensitivity analyses suggested that this association, while persisting
across the many adjusted nutrient models, was no longer
significant after adjustment for red meat. The association
between red meat consumption and NAFLD risk is increasingly being reported [42–44] although fish and other seafood are the main dietary sources of LCPUFA. However, the
1995 National Nutrition Survey from Australia showed that
close to 43% of LCPUFA intake came from meat, poultry
and game products and dishes [45], and among Australian
teenagers this proportion increased further to 49%, surpassing that of seafood sources (37%) [46]. The latest data from
the Australian Health Survey 2011–2012 showed a similar
result with the proportion of Australian adolescents consuming LCPUFA from meat, poultry and game products
and dishes (33%) slightly exceeding that of seafood sources
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(32%) [47]. Red meat as a major source of n-3 LCPUFA is
one possibility that may mediate the association found in
this study. It is also important to note that the association
between n–3 LCPUFA and FLD risk was only present in the
LH risk group, which suggests heterogeneity of the association between nutrients and FLD risk in the population.
Our study validates findings in nutritional epidemiology
regarding dietary misreporting, which is often associated
with BMI status, educational level, and age [48, 49] and
can be especially vulnerable to bias when we evaluate dietary-metabolic disease associations. Differences in dietary
characteristics between plausible (Table 2) and implausible (Supplementary Table 1) populations may result from
overweight and obese people under-reporting their intake
of dietary fats [50].

Strengths and limitations
To our knowledge, this is the first study to explore the association between dietary fat intake of adolescents with the
longitudinal natural development of fatty liver into young
adulthood. The strengths of our study include the use of
data from a large cohort with prospectively collected dietary
information minimising recall bias and representative of the
general adolescent and young adult population in Australia.
Our study focus is on the natural history of FLD risk from
adolescence to young adulthood and uses an objective and
validated fatty liver screening tool for longitudinal data
analysis over 8 years.
Our study has several limitations. First, proper interpretation of the results of the study requires consideration of
measurement errors in self-reported dietary data, unavoidable when using an FFQ [51]. We minimised this impact by
applying a less biased instrument (3 day food record) and
performing an internal calibration of the FFQ data [17], finding relative validity. Additionally, dietary misreporting was
introduced into the analysis as a covariate factor to achieve
better statistical modelling. The energy adjustment method
was further applied to minimise the impact of FFQ measurement errors in statistical modelling. Second, we used FLI, a
non-invasive, easily calculated but indirect marker that combines anthropometric indices and biochemical parameters
to predict the risk of fatty liver disease. Although useful
for large-scale epidemiological studies, it is not possible to
distinguish whether any association between dietary intake
and FLI is independent or mediated through body weight
status (body mass index and/or waist circumference), which
primarily drives FLI scores. Finally, dietary fatty acid exposure in our study was assessed only at baseline age 14 years
and is strongly associated with other nutrients and beverage intake that were not assessed as potential confounders.
Dietary habits during adolescence may change over time.
The use of only one prospective assessment of dietary intake

is a limitation of our study. We have also not accounted for
degrees of physical activity.
Our study reveals that aspects of dietary fat intake are
associated with the future risk of FLD in young populations.
While dietary fat consumption at age 14 years is unlikely to
independently lead to an increased risk of FLD 8 years later,
dietary habits established during adolescence are likely to
persist into adulthood, including into the reproductive years
[52]. Interestingly, we examined changes in the trajectory of
dietary patterns from adolescence to early adulthood (from
14, 17 to 20 years of age) in the Raine study Gen2 population [53] and found that 21% of men consuming mainly
the Western Dietary Pattern Score had a stable, significant
growth trajectory over time suggesting that dietary patterns
established during adolescence are likely to persist into early
adulthood, especially among males supporting the idea that
specific populations can still benefit from early dietary interventions. Therefore, family diet education or intervention
may be a viable way to prevent or reduce the rising prevalence of fatty liver among younger populations.
Future nutritional epidemiological studies should focus
on the pathways by which n–6 fatty acids are associated
with FLD, such as the mediation of inflammatory factors.
Additionally, a focus on risk factors for the development of
FLD is recommended, such as validating the relationships
between EPA and metabolism-related outcomes in larger
populations.

Conclusions
Our study shows that the FLI trajectory from adolescence
to young adulthood is a critical time for the development
or continuation of fatty liver. Certain aspects of fatty acid
intake in early adolescence are associated with FLI trajectories from adolescence to young adulthood. We conclude that
for those at high risk of fatty liver in early adolescence, there
may be potential benefits from including a lower N6:N3 fatty
acid diet and reducing foods high in N6 to improve the fatty
acid balance in the diet. However, great caution should be
used in extrapolating the data from this observational study
to dietary advice due to the many limitations outlined above.
Supplementary Information The online version contains supplementary material available at https://d oi.o rg/1 0.1 007/s 00394-0 22-0 2934-8.
Acknowledgements Authors would like to thank all the Raine Study
participants and their families, the Raine Study team for cohort coordination and data collection and the NHMRC for their long term contribution to funding the study. We would like to thank The University of
Western Australia, Curtin University, Telethon Kids Institute, Women
and Infants Research Foundation, Edith Cowan University, Murdoch
University, The University of Notre Dame Australia and the Raine
Medical Research Foundation for providing funding for core management of the Raine Study.

13

European Journal of Nutrition
Author contributions FW was responsible for the study design, statistical analyses, interpreted the results and wrote the manuscript; FP,
OTA, LAA, TAM and JKO advised on the statistical analysis. OTA,
LAA, TAM, LJB, TAM and WHO contributed to study design, data
collection, interpretation of data and revision of the manuscript. All
authors approved the final version of the manuscript.
Funding Open Access funding enabled and organized by CAUL and
its Member Institutions. Core funding for the Raine Study is provided
by the University of Western Australia, Curtin University, Telethon
Kids Institute, Women and Infants Research Foundation, Edith Cowan
University, Murdoch University, The University of Notre Dame Australia and the Raine Medical Research Foundation. Data collection and
biological specimens at the 14- and 17-year follow-up were funded by
the National Health and Medical Research Council (Programme grants
003209 and 353514; Project grants 211912, 403981 and 1021105). The
20-year and 22-year follow-up were funded by the National Health
and Medical Research Council (Project grants 1022134; Project grants
1027449, 1044840, and 1021855).

Declarations
Conflict of interest All authors declare no conflict of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

References
1. Ayonrinde OT (2021) Historical narrative from fatty liver in the
nineteenth century to contemporary NAFLD—reconciling the
present with the past. JHEP Rep 3(3):100261. https://doi.org/10.
1016/j.jhepr.2021.100261
2. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam
M, George J, Bugianesi E (2018) Global burden of NAFLD and
NASH: trends, predictions, risk factors and prevention. Nat Rev
Gastroenterol Hepatol 15(1):11–20. https://doi.org/10.1038/nrgas
tro.2017.109
3. Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat
Rev Gastroenterol Hepatol 10(11):686–690. https://doi.org/10.
1038/nrgastro.2013.171
4. Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran
D, Kit BK, Flegal KM (2016) Trends in obesity prevalence among
children and adolescents in the United States, 1988–1994 through
2013–2014. JAMA 315(21):2292–2299. https://doi.org/10.1001/
jama.2016.6361
5. Wiegand S, Keller KM, Robl M, L’Allemand D, Reinehr T, Widhalm K, Holl RW, Group AP-S, the German Competence Network A (2010) Obese boys at increased risk for nonalcoholic liver
disease: evaluation of 16,390 overweight or obese children and
adolescents. Int J Obes (Lond) 34(10):1468–1474. https://d oi.o rg/
10.1038/ijo.2010.106

13

6. Ryu S, Chang Y, Jung HS, Yun KE, Kwon MJ, Choi Y, Kim CW,
Cho J, Suh BS, Cho YK, Chung EC, Shin H, Kim YS (2015) Relationship of sitting time and physical activity with non-alcoholic
fatty liver disease. J Hepatol 63(5):1229–1237. https://doi.org/1 0.
1016/j.jhep.2015.07.010
7. Oddy WH, Herbison CE, Jacoby P, Ambrosini GL, O’Sullivan
TA, Ayonrinde OT, Olynyk JK, Black LJ, Beilin LJ, Mori TA,
Hands BP, Adams LA (2013) The Western dietary pattern is
prospectively associated with nonalcoholic fatty liver disease in
adolescence. Am J Gastroenterol 108(5):778–785. https://d oi.o rg/
10.1038/ajg.2013.95
8. Hodson L (2019) Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state. Proc Nutr Soc
78(1):126–134. https://doi.org/10.1017/S0029665118002653
9. Cheng Y, Zhang K, Chen Y, Li Y, Li Y, Fu K, Feng R (2016)
Associations between dietary nutrient intakes and hepatic lipid
contents in NAFLD patients quantified by (1)H-MRS and dualecho MRI. Nutrients. https://doi.org/10.3390/nu8090527
10. Zheng JS, Sharp SJ, Imamura F, Koulman A, Schulze MB, Ye
Z, Griffin J, Guevara M, Huerta JM, Kroger J, Sluijs I, Agudo A,
Barricarte A, Boeing H, Colorado-Yohar S, Dow C, Dorronsoro
M, Dinesen PT, Fagherazzi G, Franks PW, Feskens EJM, Kuhn
T, Katzke VA, Key TJ, Khaw KT, de Magistris MS, Mancini
FR, Molina-Portillo E, Nilsson PM, Olsen A, Overvad K, Palli
D, Quiros JR, Rolandsson O, Ricceri F, Spijkerman AMW,
Slimani N, Tagliabue G, Tjonneland A, Tumino R, van der
Schouw YT, Langenberg C, Riboli E, Forouhi NG, Wareham
NJ (2017) Association between plasma phospholipid saturated
fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a
cross-sectional analysis in the EPIC-InterAct study. BMC Med
15(1):203. https://doi.org/10.1186/s12916-017-0968-4
11. Marina A, von Frankenberg AD, Suvag S, Callahan HS, Kratz
M, Richards TL, Utzschneider KM (2014) Effects of dietary fat
and saturated fat content on liver fat and markers of oxidative
stress in overweight/obese men and women under weight-stable
conditions. Nutrients 6(11):4678–4690. https://doi.org/10.3390/
nu6114678
12. Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE,
Larsson A, Johansson L, Ahlstrom H, Arner P, Dahlman I,
Riserus U (2014) Overfeeding polyunsaturated and saturated
fat causes distinct effects on liver and visceral fat accumulation
in humans. Diabetes 63(7):2356–2368. https://doi.org/10.2337/
db13-1622
13. Rosqvist F, Kullberg J, Stahlman M, Cedernaes J, Heurling K,
Johansson HE, Iggman D, Wilking H, Larsson A, Eriksson O,
Johansson L, Straniero S, Rudling M, Antoni G, Lubberink M,
Orho-Melander M, Boren J, Ahlstrom H, Riserus U (2019) Overeating saturated fat promotes fatty liver and ceramides compared
with polyunsaturated fat: a randomized trial. J Clin Endocrinol
Metab 104(12):6207–6219. https://d oi.o rg/1 0.1 210/j c.2 019-0 0160
14. Liver EAfTSoT, Diabetes EAftSo (2016) EASL-EASD-EASO
Clinical Practice Guidelines for the management of non-alcoholic
fatty liver disease. Obes Fact 9(2):65–90
15. Straker L, Mountain J, Jacques A, White S, Smith A, Landau L,
Stanley F, Newnham J, Pennell C, Eastwood P (2017) Cohort
profile: the Western Australian pregnancy cohort (raine) studygeneration 2. Int J Epidemiol 46(5):1384–1385j. https://doi.org/
10.1093/ije/dyw308
16. Ambrosini GL, Oddy WH, Robinson M, O’Sullivan TA, Hands
BP, de Klerk NH, Silburn SR, Zubrick SR, Kendall GE, Stanley
FJ, Beilin LJ (2009) Adolescent dietary patterns are associated
with lifestyle and family psycho-social factors. Public Health Nutr
12(10):1807–1815. https://doi.org/10.1017/S1368980008004618
17. Ambrosini GL, O’Sullivan TA, de Klerk NH, Mori TA, Beilin LJ,
Oddy WH (2011) Relative validity of adolescent dietary patterns:

European Journal of Nutrition

18.

19.
20.

21.

22.

23.

24.

25.

26.

27.

28.
29.
30.
31.

32.

33.

a comparison of a FFQ and 3 d food record. Br J Nutr 105(4):625–
633. https://doi.org/10.1017/S0007114510004137
Ambrosini GL, de Klerk NH, O’Sullivan TA, Beilin LJ, Oddy WH
(2009) The reliability of a food frequency questionnaire for use
among adolescents. Eur J Clin Nutr 63(10):1251–1259. https://
doi.org/10.1038/ejcn.2009.44
Deo RC (2015) Machine learning in medicine. Circulation
132(20):1920–1930. https://d oi.o rg/1 0.1 161/C IRCUL ATIO
NAHA.115.001593
Huang TT, Roberts SB, Howarth NC, McCrory MA (2005)
Effect of screening out implausible energy intake reports on
relationships between diet and BMI. Obes Res 13(7):1205–
1217. https://doi.org/10.1038/oby.2005.143
Goldberg G, Black A, Jebb S et al (1991) Critical evaluation
of energy intake data using fundamental principles of energy
physiology: 1. Derivation of cut-off limits to identify underrecording. Eur J Clin Nutr 45(12):569–581
Poslusna K, Ruprich J, de Vries JH, Jakubikova M, van’t Veer
P (2009) Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice. Br J Nutr 101(S2):S73–S85. https://
doi.org/10.1017/S0007114509990602
Johansson L, Solvoll K, Bjorneboe GE, Drevon CA (1998)
Under- and overreporting of energy intake related to weight
status and lifestyle in a nationwide sample. Am J Clin Nutr
68(2):266–274. https://doi.org/10.1093/ajcn/68.2.266
Cole TJ, Flegal KM, Nicholls D, Jackson AA (2007) Body mass
index cut offs to define thinness in children and adolescents:
international survey. BMJ 335(7612):194. https://doi.org/10.
1136/bmj.39238.399444.55
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity
worldwide: international survey. BMJ 320(7244):1240–1243.
https://doi.org/10.1136/bmj.320.7244.1240
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua
M, Castiglione A, Tiribelli C (2006) The Fatty Liver Index: a
simple and accurate predictor of hepatic steatosis in the general
population. BMC Gastroenterol 6:33. https://doi.org/10.1186/
1471-230X-6-33
Wan F, Pan F, Ayonrinde OT, Adams LA, Mori TA, Beilin
LJ, O’Sullivan TA, Olynyk JK, Oddy WH (2021) Validation
of fatty liver disease scoring systems for ultrasound diagnosed
non-alcoholic fatty liver disease in adolescents. Dig Liver Dis
53(6):746–752. https://doi.org/10.1016/j.dld.2020.11.037
Nagin D (2009) Group-based modeling of development. Harvard University Press
Nagin DS (1999) Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods 4(2):139–
157. https://doi.org/10.1037/1082-989x.4.2.139
Blizzard L, Hosmer DW (2007) The log multinomial regression
model for nominal outcomes with more than two attributes.
Biom J 49(6):889–902. https://doi.org/10.1002/bimj.200610377
Doycheva I, Watt KD, Alkhouri N (2017) Nonalcoholic fatty
liver disease in adolescents and young adults: the next frontier
in the epidemic. Hepatology 65(6):2100–2109. https://doi.org/
10.1002/hep.29068
Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C,
Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118(4):1388–1393. https://doi.org/10.1542/
peds.2006-1212
Mrad RA, Merjaneh N, Mubarak G, Lopez R, Zein NN, Alkhouri N (2016) The increasing burden of nonalcoholic fatty
liver disease among young adults in the United States: a growing epidemic. Hepatology 64(4):1386–1387. https://doi.org/10.
1002/hep.28555

34. Simopoulos AP (2016) An increase in the omega-6/omega-3
fatty acid ratio increases the risk for obesity. Nutrients 8(3):128.
https://doi.org/10.3390/nu8030128
35. Bogl LH, Kaprio J, Pietilainen KH (2020) Dietary n–6 to n–3
fatty acid ratio is related to liver fat content independent of
genetic effects: evidence from the monozygotic co-twin control
design. Clin Nutr 39(7):2311–2314. https://doi.org/10.1016/j.
clnu.2019.10.011
36. Simopoulos AP (2002) The importance of the ratio of omega-6/
omega-3 essential fatty acids. Biomed Pharmacother 56(8):365–
379. https://doi.org/10.1016/s0753-3322(02)00253-6
37. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR (2011) Changes in consumption of omega-3 and
omega-6 fatty acids in the United States during the 20th century.
Am J Clin Nutr 93(5):950–962. https://doi.org/10.3945/ajcn.
110.006643
38. Anstee QM, Targher G, Day CP (2013) Progression of NAFLD
to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev
Gastroenterol Hepatol 10(6):330–344. https://doi.org/10.1038/
nrgastro.2013.41
39. Spooner MH, Jump DB (2019) Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we
stand? Curr Opin Clin Nutr Metab Care 22(2):103–110. https://
doi.org/10.1097/MCO.0000000000000539
40. Herter-Aeberli I, Graf C, Vollenweider A, Haberling I, Srikanthan P, Hersberger M, Berger G, Mathis D (2019) Validation of
a food frequency questionnaire to assess intake of n–3 polyunsaturated fatty acids in Switzerland. Nutrients. https://doi.org/
10.3390/nu11081863
41. Sublette ME, Segal-Isaacson CJ, Cooper TB, Fekri S, Vanegas
N, Galfalvy HC, Oquendo MA, Mann JJ (2011) Validation of a
food frequency questionnaire to assess intake of n–3 polyunsaturated fatty acids in subjects with and without major depressive
disorder. J Am Diet Assoc 111(1):117-123e111-112. https://doi.
org/10.1016/j.jada.2010.10.007
42. Kim MN, Lo C-H, Corey KE, Luo X, Long L, Zhang X, Chan
AT, Simon TG (2022) Red meat consumption, obesity, and the
risk of nonalcoholic fatty liver disease among women: evidence
from mediation analysis. Clin Nutr 41(2):356–364
43. Hashemian M, Merat S, Poustchi H, Jafari E, Radmard AR,
Kamangar F, Freedman N, Hekmatdoost A, Sheikh M, Boffetta
P, Sinha R, Dawsey SM, Abnet CC, Malekzadeh R, Etemadi A
(2021) Red meat consumption and risk of nonalcoholic fatty
liver disease in a population with low meat consumption: the
Golestan cohort study. Am J Gastroenterol 116(8):1667–1675.
https://doi.org/10.14309/ajg.0000000000001229
44. Peng H, Xie X, Pan X, Zheng J, Zeng Y, Cai X, Hu Z, Peng
XE (2021) Association of meat consumption with NAFLD risk
and liver-related biochemical indexes in older Chinese: a crosssectional study. BMC Gastroenterol 21(1):221. https://doi.org/
10.1186/s12876-021-01688-7
45. National Nutrition Survey: Selected highlights, Australia, 1995
(1997).
46. Howe P, Meyer B, Record S, Baghurst K (2006) Dietary intake
of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 22(1):47–53. https://doi.org/10.
1016/j.nut.2005.05.009
47. Australian Health Survey: nutrition first results—foods and
nutrients (2014).
48. Freedman LS, Commins JM, Moler JE, Arab L, Baer DJ, Kipnis
V, Midthune D, Moshfegh AJ, Neuhouser ML, Prentice RL,
Schatzkin A, Spiegelman D, Subar AF, Tinker LF, Willett W
(2014) Pooled results from 5 validation studies of dietary selfreport instruments using recovery biomarkers for energy and
protein intake. Am J Epidemiol 180(2):172–188. https://doi.
org/10.1093/aje/kwu116

13

European Journal of Nutrition
49. Trabulsi J, Schoeller DA (2001) Evaluation of dietary assessment instruments against doubly labeled water, a biomarker
of habitual energy intake. Am J Physiol Endocrinol Metab
281(5):E891-899. https://doi.org/10.1152/ajpendo.2001.281.5.
E891
50. Heitmann BL, Lissner L (1995) Dietary underreporting by obese
individuals–is it specific or non-specific? BMJ 311(7011):986–
989. https://doi.org/10.1136/bmj.311.7011.986
51. Bennett DA, Landry D, Little J, Minelli C (2017) Systematic
review of statistical approaches to quantify, or correct for,
measurement error in a continuous exposure in nutritional

13

epidemiology. BMC Med Res Methodol 17(1):146. https://doi.
org/10.1186/s12874-017-0421-6
52. Movassagh EZ, Baxter-Jones ADG, Kontulainen S, Whiting SJ,
Vatanparast H (2017) Tracking dietary patterns over 20 years
from childhood through adolescence into young adulthood: the
Saskatchewan pediatric bone mineral accrual study. Nutrients.
https://doi.org/10.3390/nu9090990
53. Appannah G, Murray K, Trapp G, Dymock M, Oddy WH, Ambrosini GL (2021) Dietary pattern trajectories across adolescence and
early adulthood and their associations with childhood and parental
factors. Am J Clin Nutr 113(1):36–46

